1. |
Margarines with sterols and stanols: better spread for IHD |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
STI 571'promises to be an important advance'in CML |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
Skip ibutilide therapy, proceed straight to DC cardioversion |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
Ganciclovir: good value for money in liver transplantation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
Interleukin-4 receptor - a breath of fresh air for asthmatics? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 7-8
Ngaire White,
Carmen Innes,
Preview
|
|
摘要:
The use of novel therapies for asthma was a topic that received much attention at the 56th Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) [San Diego, US; March 2000].'Application of molecular biology to the discovery of novel pathways to inhibit allergic tissue responses is becoming a reality',said Dr Stephen Holgate from the University of Southampton, UK, during a plenary session on immune modulation for the treatment of asthma. Promising results from the first multidose trial of interleukin (IL)-4 receptor in adults with moderate, inhaled corticosteroid-dependent asthma were presented at a late-breaker session.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
Gene therapy for pulmonary hypertension? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
Community-acquired infections - the role of gatifloxacin |
|
Inpharma Weekly,
Volume &NA;,
Issue 1231,
2000,
Page 11-12
Anoma Ranaweera,
Preview
|
|
摘要:
Kyorin's gatifloxacin ['Tequin'] is a new fluoroquinolone which is active against a wide range of pathogens, including Gram-positive and -negative bacteria, atypical pathogens and anaerobes. While it has been approved for use in the US, it is only at the phase II/III stage of development in Europe. The 8th Biennial Conference on Antiinfective Agents and Chemotherapy [Munich, Germany;March 2000] provided an opportunity for researchers to present some of the first European clinical data on this new fluoroquinolone.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|